tiprankstipranks
Trending News
More News >
OSE Immunotherapeutics SA (DE:6OP)
FRANKFURT:6OP
Germany Market

OSE Immunotherapeutics SA (6OP) Income Statement

Compare
1 Followers

OSE Immunotherapeutics SA Income Statement

Last quarter (Q2 2025), OSE Immunotherapeutics SA's total revenue was €1.32M, a decrease of -2.58% from the same quarter last year. In Q2, OSE Immunotherapeutics SA's net income was €-15.11M. See OSE Immunotherapeutics SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 69.88M€ 2.23M€ 18.30M€ 26.31M€ 10.42M
Gross Profit
€ 69.88M€ 2.23M€ 18.30M€ 26.31M€ 10.42M
Operating Expenses
€ 41.52M€ 25.21M€ 36.78M€ 42.93M€ 29.41M
Depreciation and Amortization
€ 3.36M€ 3.52M€ 3.56M€ 2.66M€ 730.00K
EBITDA
€ 41.20M€ -17.50M€ -13.11M€ -13.72M€ -18.24M
Operating Income
€ 43.73M€ -22.99M€ -18.48M€ -16.63M€ -18.99M
Other Income/Expenses
€ -3.90M€ -235.00K€ 454.00K€ -588.00K€ -257.00K
Pretax Income
€ 39.83M€ -23.22M€ -23.45M€ -21.56M€ -19.25M
Net Income
€ 37.45M€ -23.00M€ -17.76M€ -16.85M€ -16.55M
Per Share Metrics
Basic EPS
€ 1.72€ -1.18€ -0.96€ -0.93€ -1.06
Diluted EPS
€ 1.72€ -1.18€ -0.96€ -0.93€ -1.06
Weighted Average Shares Outstanding
21.81M 19.56M 18.46M 18.16M 15.56M
Weighted Average Shares Outstanding (Diluted)
21.81M 19.56M 18.46M 18.16M 15.56M
Currency in EUR

OSE Immunotherapeutics SA Earnings and Revenue History